Please login to the form below

Not currently logged in
Email:
Password:

insuline glargine

This page shows the latest insuline glargine news and features for those working in and with pharma, biotech and healthcare.

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

Lilly/ Boehringer's Lantus biosimilar accepted for EMA review

The decision by the European Medicines Agency (EMA) moves the Lilly/ Boehringer insulin glargine biosimilar, known as LY2963016, one step closer to the market. ... Gwen Krivi, VP, Lilly Diabetes product development, said: "Long-acting insulin is a

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

image 1
Redefining communications excellence
How to be heard in today’s multichannel, multistakeholder, multimedia world...
AZ Campus
AstraZeneca: building a new ‘open innovation’ pharma company
The construction of its new HQ has suffered some serious delays, but new R&D and commercial success are lifting AstraZeneca’s prospects...
Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...

Infographics